Registration Dossier

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
not specified
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Justification for type of information:
Fluvoxamine Base provides the pharmacologic and toxicological propierties of this compound.
Maleate counterion is pharmacologically acceptable and not dangerous.
Thus, Fluvoxamine Base classification is based on Fluvoxamine Maleate.

Data source

Reference
Reference Type:
other: MSDS
Title:
USP

Materials and methods

Test animals

Species:
rat
Strain:
not specified
Sex:
not specified

Administration / exposure

Route of administration:
inhalation

Results and discussion

Effect levels
Key result
Sex:
not specified
Dose descriptor:
LC50
Effect level:
ca. 1 030 mg/m³ air
Exp. duration:
4 h

Applicant's summary and conclusion